
Publication|Articles|January 1, 2025
- Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Author(s)Azurity Pharmaceuticals
Key Takeaways
- Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
- Stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies, offering less invasive options.
This article is sponsored by Azurity Pharmaceuticals, Inc.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
5





































































































